Scientific misconduct in a breast-cancer chemotherapy trial: response of University of the Witwatersrand-Reference-Cited by-同舟云学术

Scientific misconduct in a breast-cancer chemotherapy trial: response of University of the Witwatersrand

Published:2000-03 Issue:9208 Volume:355 Page:1011-1012
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cleaton-Jones Peter

Publisher

Elsevier BV

Subject

General Medicine

Reference4 articles.

1. South African Medical Research Council. Guidelines on ethics for medical research; revised edition. Tygerberg: SAMRC, 1993. Available on http://www.mrc.ac.za/Ethics/ethics.htm (accessed March 8, 2000.

2. Committee for Research on Human Subjects (Medical) of the University of the Wiwatersrand. Available on http://www.wits.ac.za/research/ethics.htm (accessed March 8, 2000).

3. WR Bezwoda. Randomised, controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer. Available on http://www.conference-cast.com/asco/abstract_frame.htm (accessed March 8, 2000).

4. Fraud and misconduct in medical research;Lock,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monozentrische Studie;Handbuch Ethik und Recht der Forschung am Menschen;2014

2. Promoting Research Integrity in Africa: An African Voice of Concern on Research Misconduct and the Way Forward;Developing World Bioethics;2013-04-17

3. MODULE SIX: SPECIAL ISSUES;Developing World Bioethics;2005-03

4. MODULE FIVE: IMPLEMENTATION OF ETHICS REVIEW;Developing World Bioethics;2005-03

5. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer;Cancer Treatment Reviews;2000-06